Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02004132 | A Study of Axiron® in Healthy Participants | PHASE1 | COMPLETED | 12 | — | — | Dec 1, 2013 | Dec 1, 2013 | Aug 19, 2014 | 1 | United States |
This is a summary of the amounts of testosterone measured on a 10 centimeters (cm) × 10 cm of material excised from the underarm area of participant's unwashed t-shirt halves.
| Arm | Type | Description |
|---|---|---|
| Axiron | EXPERIMENTAL | Axiron administered topically via metered dose pump to each underarm on Day 1 |
| Name | Type | Description |
|---|---|---|
| Axiron | DRUG | Solution administered topically using pump and applicator |
Inclusion Criteria: * Are overtly healthy males, as determined by medical history and physical examination, or males who have been on stable medication for at least 1 month and have no significant clinical conditions. * Agree to use a reliable method of birth control (for example: condom or vasecto...